National Jewish Health offers Complement activation and biomarker expertise, in vitro human safety data, preclinical and clinical functional/phenotypic assays to support biologics, vaccines and oligonucleotide based drug discovery and development programs. Our laboratories are CAP/CLIA, ISO 15189 certified and conduct both GLP and Non-GLP contract services, experienced supporting hundreds of FDA filings.